✦ LIBER ✦

Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer

✍ Scribed by Paul Mathew; Isaiah J Fidler; Christopher J Logothetis

Book ID: 114473533
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 310 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2004.03.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Receptor tyrosine kinases as rational ta

Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate

✍ Daniel J George 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Imatinib mesylate inhibits platelet-deri

Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma

✍ Rieko Katayama; Michael K. Huelsmeyer; Amanda K. Marr; Ilene D. Kurzman; Douglas 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 476 KB

Imatinib mesylate responsiveness in aggr

Imatinib mesylate responsiveness in aggressive systemic mastocytosis: Novel association with a platelet derived growth factor receptor beta mutation

✍ Bakul I. Dalal; Douglas E. Horsman; Hélène Bruyèrè; Donna L Forrest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 1 views

Platelet-derived growth factor receptor

Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

✍ Tadahiko Kubo; Sajida Piperdi; Jeremy Rosenblum; Cristina R. Antonescu; Wen Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of platelet‐derived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom

Inhibition of platelet-derived growth fa

Inhibition of platelet-derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro

✍ F. Fierro; T. Illmer; D. Jing; E. Schleyer; G. Ehninger; S. Boxberger; M. Bornhä 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Platelet-derived growth factor receptor

Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate

✍ Brian L. Swick; Larisa Ravdel; James E. Fitzpatrick; William A. Robinson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB